Skip to main content
S 1806 104th Congress Senate Health Agriculture and Food Commerce Dietary supplements Drug abuse Drugs Labeling Psychotropic drugs

A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall…

Show full title

A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.

Introduced: May 23, 1996 See on congress.gov
This bill died when the 104th Congress ended
It never became law before the 104th Congress (1995–1996) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 23, 1996
Read twice and referred to the Committee on Labor and Human Resources.
May 23, 1996
Sponsor introductory remarks on measure. (CR S5582-5583)
May 23, 1996
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Amends the Federal Food, Drug, and Cosmetic Act to consider a dietary supplement a drug if its labeling claims or implies that the supplement produces euphoria, heightened awareness, or similar mental or psychological effects.

What's happening now May 23, 1996

Read twice and referred to the Committee on Labor and Human Resources.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1806: A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.. 104th Congress. Open America. https://openamerica.io/bill/104-S-1806/
MLA
"S. 1806: A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-S-1806/.
Bluebook (legal)
S. 1806, 104th Cong. (2026), https://openamerica.io/bill/104-S-1806/.
Markdown link
[S. 1806: A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.](https://openamerica.io/bill/104-S-1806/)
Report a problem